NIBR President Jay Bradner’s natural inclination as a scientist is to tackle long-standing healthcare challenges to change the practice of medicine. Talking to Monocle, Bradner explains how open science can help researchers find new drug targets through smart collaborations. Meanwhile, he explains that much of his motivation and drive to reimagine drug discovery comes from the fact that drug hunting is similar to gambling – as regards both the odds and the addictiveness of the determination to win. For the future of medicine this can only be positive.

Published on 04/06/2021